| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 181 / 669 | 73rd | Q2 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Intractable and Rare Diseases Research
Intractable and Rare Diseases Research is Scopus-indexed (Q2, CiteScore 3.2), WoS ESCI. Published by International Advancement Center for Medicine and Health Research Co., Ltd..
Checked against the index lists dated .
ISSN 2186-361XVerify ISSN ↗2186-3644Verify ISSN ↗
Publisher: International Advancement Center for Medicine and Health Research Co., Ltd.
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Intractable and Rare Diseases Research indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 3.2.
What quartile is Intractable and Rare Diseases Research in Scopus?
Intractable and Rare Diseases Research is Q2 in Medicine (all) (rank 181 of 669), by CiteScore 2025.
What is the impact factor of Intractable and Rare Diseases Research?
Intractable and Rare Diseases Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q2 at the 73rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.547, quartile Q2, with an H-index of 38.
Who publishes Intractable and Rare Diseases Research and what is its ISSN?
Intractable and Rare Diseases Research is published by International Advancement Center for Medicine and Health Research Co., Ltd. Its print ISSN is 2186-361X and its online ISSN is 2186-3644.
Is Intractable and Rare Diseases Research in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is Intractable and Rare Diseases Research open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Intractable and Rare Diseases Research? — open metrics via OpenAlex
Intractable and Rare Diseases Research has an h-index of 47 and a 2-year mean of 2.44 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #111 of 646 Scopus journals in Medicine (all).
Intractable and Rare Diseases Research published 41 papers in 2025; its busiest recent year was 2017 with 57. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Intractable and Rare Diseases Research? — latest 95 articles, 2024–2026
In its latest 95 research articles (2024–2026), authors are most often from China (53.7%), Japan (18.9%) and United States (4.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Intractable and Rare Diseases Research? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration53.7% of recent authorship from China
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.